LAUSR

Bring Your Own Device (BYOD) studies allow patients participating in clinical trials to complete electronic Clinical Outcome Assessments (eCOAs) with their personal smartphones, tablets, or computers, all using a single cross-platform application. Across the Life Sciences industry, there has been a great deal of discussion regarding the potential benefits of the BYOD approach, including: reduced costs for the study sponsor; reduction in study start-up timelines; reduced patient burden due to increased familiarity with the device and operating system; and compliance rates that improve upon already high eCOA compliance using provisioned devices [1].